Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effect of briefly heating cyclophosphamide solutions.

D Brooke, J A Scott, R J Bequette

    American Journal of Hospital Pharmacy
    |January 1, 1975
    PubMed
    Summary

    Heating cyclophosphamide monohydrate solutions above 60°C significantly reduces drug potency. This study demonstrates that warming injectable cyclophosphamide can compromise its effectiveness, impacting patient treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Worker risk from ultrasonicator aerosolization in medical device reprocessing: a particulate and bio-burden approach.

    The Journal of hospital infection·2025
    Same author

    Impact of postpartum hospital length of stay on infant gut microbiota: a comprehensive analysis of vaginal and caesarean birth.

    The Journal of hospital infection·2024
    Same author

    Brain Charts for the Rhesus Macaque Lifespan.

    bioRxiv : the preprint server for biology·2024
    Same author

    High-content phenotypic screening identifies novel chemistries that disrupt mosquito activity and development.

    Pesticide biochemistry and physiology·2022
    Same author

    What factors shape surgical access in West Africa? A qualitative study exploring patient and provider experiences of managing injuries in Sierra Leone.

    BMJ open·2021
    Same author

    Management of superior mesenteric venous thrombus in cystic fibrosis related liver disease.

    Paediatric respiratory reviews·2020

    Area of Science:

    • Pharmaceutical Science
    • Drug Stability
    • Chemical Kinetics

    Background:

    • Cyclophosphamide monohydrate is a widely used chemotherapy agent.
    • Ensuring the stability and potency of injectable drug formulations is critical for therapeutic efficacy.
    • Rapid dissolution techniques may involve heating, potentially affecting drug integrity.

    Purpose of the Study:

    • To investigate the impact of elevated temperatures on the stability and potency of cyclophosphamide monohydrate solutions.
    • To quantify the degradation of cyclophosphamide monohydrate at various temperatures.
    • To compare experimental results with theoretical predictions using the Arrhenius equation.

    Main Methods:

    • Aqueous solutions of cyclophosphamide monohydrate were prepared.
    • Solutions were subjected to controlled heating at 50°C, 60°C, 70°C, and 80°C for 15 minutes.
    • Post-heating, the potency of the cyclophosphamide monohydrate solutions was determined through assay.

    Main Results:

    • Solutions heated to 50°C and 60°C showed no significant loss in potency.
    • Heating to 70°C resulted in a potency loss to 90.2% of the initial value.
    • Heating to 80°C led to a substantial decrease in potency, assaying at 77.5% of the initial value.
    • Observed degradation trends correlated well with predictions from the Arrhenius equation.

    Conclusions:

    • Warming cyclophosphamide monohydrate solutions, particularly above 60°C, can lead to a significant decrease in drug potency.
    • The findings suggest that current practices of warming vials for rapid dissolution may compromise the final injectable product's effectiveness.
    • Careful control of temperature during preparation is essential to maintain the integrity and therapeutic value of cyclophosphamide monohydrate formulations.

    Related Experiment Videos